1. Home
  2. People

Carryn Anderson, MD

Clinical Professor of Radiation Oncology

Current Positions

  • Clinical Professor of Radiation Oncology

Education

  • BA in Major: Biology, Minor: Spanish, Luther College
  • MD in Medicine, University of Texas Medical Branch
  • Internship, Cleveland Clinic, Cleveland, Ohio, United States
  • Resident in Radiation Oncology, Cleveland Clinic, Cleveland, Ohio

Research Interests

  • Phase III Clinical Trial of Dusquetide to alleviate oral mucositis in head and neck cancer patients receiving chemoRT - Soligenix, Inc.
  • Prospective trial of Triphasic Dynamic PET/CT 3-months Post-RT in Head and Neck Cancer
  • PET/CT Imaging Analysis, Auto segmentation tools, UO-1
  • Neoadjuvant Intralesional Injection of Talimogene Laherparepvec with Concurrent Preoperative Radiation in Patients with Locally Advanced Soft Tissue Sarcomas IRB #201504731
  • Retrospective review of PET-CT accuracy in post-RT head and neck patients
  • Phase I-III trials of MnSOD mimetic to decrease oral mucositis during head and neck chemoradiation - Galera Therapeutics
  • Phase I trial of a ketogenic diet with concurrent chemoradiation for head and neck cancer.
  • Prospective trial of Triphasic Dynamic PET/CT 3-months Post-RT in Head and Neck Cancer
  • Retrospective review of PET-CT accuracy in post-RT head and neck patients

Licenses & Certifications

  • Board Certified Radiation Oncologist, American Board of Radiology
  • Ohio Medical License, Ohio
  • Iowa Medical License, Iowa

Selected Publications

  • Atienza C, Shepard A, Uzomah U, Raja S, Anderson CM, Katzer J, Rusu S, St-Aubin J, Smith B, Hyer D.  Preliminary experience using MR-guided adaptive radiotherapy in head and neck cancer. Front. Oncol., 07 November 2024 Sec. Radiation Oncology Vol 14, 2024. Doi.org/10.3389/fonc2024.1474115.
  • Gobbo M, Joy J, Guedes H, Shazib MA, Anderson C, Abdalla-Aslan R, Peechatanan K, Lajolo C, Nasir KS, Gueiros LA, Nagarajan N, Hafezi Motlagh K, Kandwal A, Rupe C, Xu Y, Ehrenpreis ED, Tonkaboni A, Epstein JB, Bossi P, Wardill HR, Graff SL. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents. Expert Opin Pharmacother. 2024 Apr;25(6):727-742. doi: 10.1080/14656566.2024.2354451. Epub 2024 May 29. PMID: 38808634.
  • Mapuskar KA, Pulliam CF, Tomanek-Chalkley A, Rastogi P, Wen H, Dayal S, Griffin BR, Zepeda-Orozco D, Sindler AL, Anderson CM, Beardsley R, Kennedy EP, Spitz DR, Allen BG. The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury. Redox Biol. 2024 Apr;70:103022. doi: 10.1016/j.redox.2023.103022. Epub 2024 Jan 1. PMID: 38215546; PMCID: PMC10821164.
  • Hoffman HT, Koch M, Witt RL, Ryan WR, Zenk J, Katz P, Rahmati R, Rassekh C, Donato F, McCulloch TM, Joshi AS, Chang JL, Gillespie MB, Pichardo PFA, Orloff LA, Marcelino A, Wenzel P, Cohen D, Fundakowski CE, Cognetti DM, Walvekar RR, Bertelli A, Quon H, Anderson C, Policeni B, Siegel G. Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular gland. Laryngoscope Investig Otolaryngol. 2024 Feb 14;9(1):e1224. doi: 10.1002/lio2.1224. PMID: 38362174; PMCID: PMC10866606.
  • Allen BG, Spitz DR, Mapuskar KA Zepeda-Orozco D, Beardsley RA, Holmlund J, Anderson CM  One-year chronic kidney disease (CKD) outcomes in patients with head and neck (HNC) cancer treated with the selective dismutase mimetic avasopasem manganese: A prespecified analysis from the ROMAN trial.  Submitted to ASCO abstract 398376 December 2022
  • Smile TD and Anderson CM. Postoperative Radiotherapy for Head and Neck Cancer. Essentials of Clinical Radiation Oncology. Second Edition. Springer. 2021
  • Sonis ST, Anderson CM. Avasopasem for the treatment of radiotherapy-induced severe oral mucositis. Expert Opin Investig Drugs. 2023 Jan-Jun;32(6):463-470. doi: 10.1080/13543784.2023.2230117. Epub 2023 Jul 3. PMID: 37365149.
  • Allen BG, Spitz DR, Mapuskar KA, Zepeda-Orozco D, Beardsley R, Kennedy E, Anderson C.  One-Year Chronic Kidney Disease Outcomes in Patients with Head and Neck Cancer Treated with Avasopasem Manganese.:  A Prespecified Analysis From the Phase E ROMAN Trial.  J Clinic Oncolo 2023; 41 (supple_16) Abstract 6066. https://doi: 10.1200/JCPO.2023.41.16 suppl.6066.
  • Anderson CM. In Reply to Topkan et al. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):1010. doi: 10.1016/j.ijrobp.2022.11.020. PMID: 36822775.
  • Anderson CM, Lee CM, Saunders D, Curtis AE, Dunlap NE, Nangia C, Lee AS, Kovoor P, Bar-Ad V, Pedadda AV Jr, Holmlund J, Downs M, Sonis ST. Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):416-421. doi: 10.1016/j.ijrobp.2022.06.063. Epub 2022 Jun 17. PMID: 35724774.